Skip to content

Study on the effect and mechanism of transcranial direct current on patients with post-stroke cognitive impairment

Study on the effect and mechanism of transcranial direct current on patients with post-stroke cognitive impairment

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072560
Enrollment
Unknown
Registered
2023-06-16
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

tDCS Group:tDCS group will receive 20 minutes of 2mA tDCS stimulation
sham group:sham stimulation group will receive 20 minutes of sham stimulation

Sponsors

Shenzhen Longhua District Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 18-80 years; clinical and imaging examinations supporting a stroke diagnosis and the presence of cognitive impairment in any of the dimensions of memory, attention, executive ability, visuospatial, language, or an initial assessed MMSE score <27/30 or MoCA score <22/30; no history of psychiatric or other neurological disorders; and willingness to participate in the study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria: age less than 18 years or more than 80 years; no symptoms of post-stroke cognitive impairment; presence of other neurological or psychiatric disorders; presence of intracranial metal foreign body or device implantation, epilepsy, serious organic disease such as severe heart disease, liver or kidney insufficiency; allergic reaction or contraindication to transcranial direct current therapy; inability to complete cognitive test assessment; refusal to participate in the study or inability to sign an informed consent form.

Design outcomes

Primary

MeasureTime frame
Attention;Memory;Executive Function;language;Visuospatial Function ;

Secondary

MeasureTime frame
EEG;Safety and tolerability standardization scales;

Countries

China

Contacts

Public ContactXiaoyun Zhang

Shenzhen Longhua District Central Hospital

zxycn86@outlook.com+86 755 2801 2861

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026